Fingerprint
Dive into the research topics of 'Nivolumab plus ipilimumab in advanced non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab plus ipilimumab in advanced non-small-cell lung cancer
M. D. Hellmann, L. Paz Ares, R. Bernabe Caro, B. Zurawski, S. W. Kim, E. Carcereny Costa, K. Park, A. Alexandru, L. Lupinacci, E. De La Mora Jimenez, H. Sakai, I. Albert, A. Vergnenegre, S. Peters, K. Syrigos, F. Barlesi, M. Reck, H. Borghaei, J. R. Brahmer, K. J. O fByrn
- Memorial Sloan-Kettering Cancer Center
- Hospital Universitario 12 de Octubre
- Hospital Universitario Virgen del Rocio
- Ambulatorium Chemioterapii
- Generalitat de Catalunya
- Sungkyunkwan University
- Oncology Institute Professor Doctor Alexandru Trestioreanu
- Hospital Italiano de Buenos Aires
- Instituto Jalisciense de Cancerologia
- Saitama Cancer Center
- Matrai Gyogyintezet
- CHU de Limoges
- University of Lausanne
- National and Kapodistrian University of Athens
- Aix-Marseille University
- German Center for Lung Research
- Johns Hopkins University
- Princess Alexandria Hospital
- Bristol-Myers Squibb
- Emory University
Research output: Contribution to journal › Article › peer-review
1984
Scopus
citations